Publication & Citation Trends
Publications
0 total
Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation. OA
Cited by 69
Semantic Scholar
Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters. OA
Cited by 39
Semantic Scholar
Discovery of NV-5138, the first selective Brain mTORC1 activator OA
Cited by 57
Semantic Scholar
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling OA
Cited by 80
Semantic Scholar
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis OA
Cited by 91
Semantic Scholar
The Selective Sirtuin 1 Activator SRT2104 Reduces Endotoxin-Induced Cytokine Release and Coagulation Activation in Humans*
Cited by 63
Semantic Scholar
PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS
Cited by 46
Semantic Scholar
Sirt1 Activation Markedly Alters Transcription Profiles and Improves Outcome in Experimental Sepsis.
Cited by 8
Semantic Scholar
Sirtuin 1 activator SRT2104 protects Huntington's disease mice OA
Cited by 49
Semantic Scholar
Research Topics
Blood Coagulation and Thrombosis Mechanisms
(12)
Venous Thromboembolism Diagnosis and Management
(5)
Bacterial Genetics and Biotechnology
(4)
Heart Failure Treatment and Management
(4)
RNA and protein synthesis mechanisms
(4)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
State University of New York
Kent State University
United States Military Academy
University of South Florida